Clinical significance of tryptophan catabolism in Hodgkin lymphoma

被引:25
作者
Masaki, Ayako [1 ,2 ]
Ishida, Takashi [1 ]
Maeda, Yasuhiro [3 ]
Ito, Asahi [1 ]
Suzuki, Susumu [4 ]
Narita, Tomoko [1 ]
Kinoshita, Shiori [1 ]
Takino, Hisashi [2 ]
Yoshida, Takashi [1 ]
Ri, Masaki [1 ]
Kusumoto, Shigeru [1 ]
Komatsu, Hirokazu [1 ]
Inagaki, Hiroshi [2 ]
Ueda, Ryuzo [4 ]
Choi, Ilseung [5 ]
Suehiro, Youko [5 ]
Iida, Shinsuke [1 ]
机构
[1] Nagoya City Univ, Dept Hematol & Oncol, Grad Sch Med Sci, Nagoya, Aichi, Japan
[2] Nagoya City Univ, Dept Anat Pathol & Mol Diagnost, Grad Sch Med Sci, Nagoya, Aichi, Japan
[3] Nagoya City Univ, Lab Hosp Pharm, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan
[4] Aichi Med Univ, Dept Tumor Immunol, Sch Med, Nagakute, Aichi, Japan
[5] Natl Kyushu Canc Ctr, Dept Hematol, Fukuoka, Japan
关键词
Hodgkin lymphoma; indoleamine; 2; 3-dioxygenase; innate immunity; kynurenine; tryptophan; TUMOR-ASSOCIATED MACROPHAGES; INDOLEAMINE 2,3-DIOXYGENASE; SOLUBLE CD30; PROGNOSTIC-SIGNIFICANCE; SERUM-LEVELS; T-CELLS; DISEASE; CANCER; EXPRESSION; IDO;
D O I
10.1111/cas.13432
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Indoleamine 2,3-dioxygenase 1 (IDO) is an enzyme catabolizing tryptophan (Trp) into the kynurenine (Kyn) pathway. The purpose of the present study was to determine the clinical significance of Trp catabolism in newly diagnosed Hodgkin lymphoma (HL) patients. We quantified serum Trp and Kyn in 52 HL patients, and analyzed their associations with different clinical parameters including serum soluble CD30 concentration. The IDO expression was evaluated in the patients' affected lymph nodes. The cohort comprised 22 male and 30 female patients (age range, 15-81years; median, 45years), with a 5-year overall survival (OS) of 88.6%. The OS was significantly shorter for patients with a high Kyn/Trp ratio (OS at 5years, 60.0% vs 92.2%), for those with stage IV disease, and for those with lymphocytopenia (<600/mm(3) and/or <8% white blood cell count). The latter two parameters are components of the international prognostic score for advanced HL. In contrast, there were no significant differences in OS according to age, serum albumin, hemoglobin, sex, white blood cell count, or serum soluble CD30 ( or <285.6ng/mL). Multivariate analysis using the three variables stage, lymphocytopenia, and serum Kyn/Trp ratio showed that only the latter significantly affected OS. Indoleamine 2,3-dioxygenase 1 was produced by macrophages/dendritic cells, but not by HL tumor cells, and IDO levels determined by immunohistochemistry had a significant positive correlation with the serum Kyn/Trp ratio. In conclusion, quantification of serum Kyn and Trp is useful for predicting prognosis of individual HL patients.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
[21]   The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas [J].
Sonner, Jana K. ;
Deumelandt, Katrin ;
Ott, Martina ;
Thome, Carina M. ;
Rauschenbach, Katharina J. ;
Schulz, Sandra ;
Munteanu, Bogdan ;
Mohapatra, Soumya ;
Adam, Isabell ;
Hofer, Ann-Cathrin ;
Feuerer, Markus ;
Opitz, Christiane A. ;
Hopf, Carsten ;
Wick, Wolfgang ;
Platten, Michael .
ONCOIMMUNOLOGY, 2016, 5 (12)
[22]   Clinical significance of urinary albumin excretion in patients with non-Hodgkin's lymphoma [J].
Pedersen, LM ;
Sorensen, PG .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (04) :889-891
[23]   Dysregulation of Tryptophan Catabolism in Metabolic Syndrome [J].
Mallmann, Neila Hiraishi ;
Lima, Emerson Silva ;
Lalwani, Pritesh .
METABOLIC SYNDROME AND RELATED DISORDERS, 2018, 16 (03) :135-142
[24]   Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma [J].
Sakatani, Akio ;
Igawa, Takuro ;
Okatani, Takeshi ;
Fujihara, Megumu ;
Asaoku, Hideki ;
Sato, Yasuharu ;
Yoshino, Tadashi .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2020, 60 (03) :78-86
[25]   Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma [J].
Agrusa, Jennifer E. ;
Scull, Brooks P. ;
Abhyankar, Harshal A. ;
Lin, Howard ;
Ozuah, Nmazuo W. ;
Chakraborty, Rikhia ;
Eckstein, Olive S. ;
Gulati, Nitya ;
Fattah, Elmoataz Abdel ;
El-Mallawany, Nader K. ;
Rouce, Rayne H. ;
Dreyer, ZoAnn E. ;
Brackett, Julienne ;
Margolin, Judith F. ;
Lubega, Joseph ;
Horton, Terzah M. ;
Bollard, Catherine M. ;
Gramatges, M. Monica ;
Kamdar, Kala Y. ;
McClain, Kenneth L. ;
Man, Tsz-Kwong ;
Allen, Carl E. .
CANCERS, 2020, 12 (12) :1-13
[26]   Clinical significance of plasma tryptophan, kynurenine, and kynurenine/tryptophan ratio in rheumatoid arthritis patients [J].
Kor, Ahmet ;
Erten, Sukran ;
Yurt, Emine F. ;
Dogan, Ismail ;
Apaydin, Hakan ;
Aserdar, Muhittin ;
Bicer, Cemile .
EGYPTIAN RHEUMATOLOGIST, 2022, 44 (04) :367-371
[27]   Serum biomarkers and clinical characteristics of patients with Hodgkin lymphoma [J].
Simonovic, Olivera ;
Todorovic, Milena ;
Mihaljevic, Biljana ;
Stoimenov-Jevtovic, Tatjana ;
Petkovic, Ivan ;
Macukanovic-Golubovic, Lana ;
Marjanovic, Goran .
VOJNOSANITETSKI PREGLED, 2018, 75 (09) :911-917
[28]   SEOM clinical guidelines for the treatment of Hodgkin's lymphoma [J].
Rueda Dominguez, A. ;
Alfaro Lizaso, J. ;
de la Cruz-Merino, L. ;
Guma i Padro, J. ;
Quero Blanco, C. ;
Gomez Codina, J. ;
Llanos Munoz, M. ;
Martinez Banaclocha, N. ;
Rodriguez Abreu, D. ;
Provencio Pulla, M. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12) :1005-1013
[29]   NFkB Pathway and Hodgkin Lymphoma [J].
Jardin, Fabrice .
BIOMEDICINES, 2022, 10 (09)
[30]   The translational science of hodgkin lymphoma [J].
Cirillo, Melita ;
Reinke, Sarah ;
Klapper, Wolfram ;
Borchmann, Sven .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (01) :30-44